Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Spencer S. StilesPresident & COO | -1,61k | 0,00 | Other Disposition | - | 77,72k | -2,03% |
| 2026-05-28 | Mr. Robert S. FletcherVP & Chief Legal Officer | -4,54k | 1,39M | Automatic Disposition | 304,23 - 310,22 | 10,77k | -29,68% |
| 2026-05-26 | Ms. Ronda E. StrykerIndependent Director | -310,00k | 96,79M | Verkauf | 310,77 - 315,11 | 14,82M | -2,05% |
| 2026-05-11 | Ms. M. Kathryn FinkVP & Chief HR Officer | -3,50k | 992,09k | Verkauf | 283,45 | 12,84k | -21,42% |
| 2026-05-08 | Ms. M. Kathryn FinkVP & Chief HR Officer | -21,58k | 2,67M | Derivative Exercise and Sale | 154,14 - 294,23 | 12,84k | - |
| 2026-03-21 | Mr. Spencer S. StilesPresident & COO | -430,00 | 144,34k | Derivative Exercise and Sale | 335,67 | 79,30k | - |
| 2026-03-21 | Mr. Spencer S. StilesPresident & COO | -6,26k | 2,10M | Sale to Issuer | 335,67 | 79,30k | -7,32% |
| 2026-03-21 | Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology | -430,00 | 144,34k | Derivative Exercise and Sale | 335,67 | 81,12k | - |
| 2026-03-21 | Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology | -7,38k | 2,48M | Sale to Issuer | 335,67 | 81,12k | -8,34% |
| 2026-03-21 | Mr. Viju S. MenonGroup President of Global Quality & Operations | -269,00 | 90,30k | Derivative Exercise and Sale | 335,67 | 17,58k | - |
| 2026-03-21 | Mr. Viju S. MenonGroup President of Global Quality & Operations | -4,45k | 1,49M | Sale to Issuer | 335,67 | 17,58k | -20,20% |
| 2026-03-21 | Mr. Kevin A. LoboChairman & CEO | -1,45k | 487,39k | Derivative Exercise and Sale | 335,67 | 222,95k | - |
| 2026-03-21 | Mr. Kevin A. LoboChairman & CEO | -25,04k | 8,41M | Sale to Issuer | 335,67 | 222,95k | -10,10% |
| 2026-03-21 | Mr. Robert S. FletcherVP & Chief Legal Officer | -225,00 | 75,53k | Derivative Exercise and Sale | 335,67 | 15,29k | - |
| 2026-03-21 | Mr. Robert S. FletcherVP & Chief Legal Officer | -3,16k | 1,06M | Sale to Issuer | 335,67 | 15,29k | -17,12% |
| 2026-03-21 | Ms. M. Kathryn FinkVP & Chief HR Officer | -150,00 | 50,35k | Derivative Exercise and Sale | 335,67 | 16,32k | - |
| 2026-03-21 | Ms. M. Kathryn FinkVP & Chief HR Officer | -1,91k | 642,47k | Sale to Issuer | 335,67 | 16,32k | -10,50% |
| 2026-03-21 | Mr. Preston W. WellsVP & CFO | -204,00 | 68,48k | Sale to Issuer | 335,67 | 6,79k | -2,92% |
| 2026-03-21 | Mr. Dylan B. CrottyGroup President of Orthopaedics | -368,00 | 123,53k | Sale to Issuer | 335,67 | 14,12k | -2,54% |
| 2026-03-21 | Mr. William E. BerryVP & CAO | -176,00 | 59,08k | Sale to Issuer | 335,67 | 1,23k | -12,49% |
| 2026-02-23 | Ms. Ronda E. StrykerIndependent Director | -55,60k | 0,00 | Other Disposition | - | 15,13M | -0,37% |
| 2026-02-13 | Ms. Ronda E. StrykerIndependent Director | -642,20k | 0,00 | Other Disposition | - | 15,18M | -4,06% |
| 2026-02-04 | Ms. Ronda E. StrykerIndependent Director | -500,00k | 181,72M | Verkauf | 358,51 - 368,56 | 15,82M | -3,06% |
| 2026-02-06 | Mr. Kevin A. LoboChairman & CEO | 74,55k | 7,20M | Derivative Exercise and Retained Stock | 96,64 | 197,66k | 60,55% |
| 2026-02-06 | Mr. Kevin A. LoboChairman & CEO | -132,41k | 35,19M | Derivative Exercise and Sale | 96,64 - 362,42 | 197,66k | - |
| 2026-02-03 | Mr. Spencer S. StilesPresident & COO | 6,15k | 594,14k | Derivative Exercise and Retained Stock | 96,64 | 70,65k | 9,53% |
| 2026-02-03 | Mr. Spencer S. StilesPresident & COO | -7,69k | 2,09M | Derivative Exercise and Sale | 96,64 - 368,14 | 70,65k | - |
| 2026-02-02 | Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology | 4,93k | 476,73k | Derivative Exercise and Retained Stock | 96,64 | 73,58k | 7,19% |
| 2026-02-02 | Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology | -8,91k | 2,43M | Derivative Exercise and Sale | 96,64 - 369,56 | 73,58k | - |
| 2026-01-15 | Mr. Andrew K. SilvernailIndependent Director | 3,34k | 322,87k | Derivative Exercise and Retained Stock | 96,64 | 12,69k | 35,74% |
| 2026-01-15 | Mr. Andrew K. SilvernailIndependent Director | -1,23k | 322,92k | Derivative Exercise and Sale | 96,64 - 359,39 | 12,69k | - |
| 2026-01-14 | Ms. Ronda E. StrykerIndependent Director | 4,57k | 441,64k | Derivative Exercise and Retained Stock | 96,64 | 16,32M | 0,03% |
| 2025-12-16 | Ms. M. Kathryn FinkVP & Chief HR Officer | -37,00 | 13,15k | Sale to Issuer | 355,31 | 13,01k | -0,28% |
| 2025-12-16 | Mr. William E. BerryVP & CAO | -28,00 | 9,95k | Sale to Issuer | 355,31 | 829,00 | -3,27% |
| 2025-11-21 | Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology | -211,00 | 0,00 | Other Disposition | - | 68,65k | -0,31% |
| 2025-11-20 | Mr. Preston W. WellsVP & CFO | -165,00 | 60,37k | Verkauf | 365,88 | 6,98k | -2,31% |
| 2025-11-14 | Mr. William E. BerryVP & CAO | -4,93k | 1,06M | Derivative Exercise and Sale | 154,14 - 373,42 | 613,00 | - |
| 2025-11-05 | Ms. Ronda E. StrykerIndependent Director | -520,00k | 184,61M | Verkauf | 349,95 - 359,79 | 16,32M | -3,09% |
| 2025-11-01 | Mr. Preston W. WellsVP & CFO | -404,00 | 143,92k | Sale to Issuer | 356,24 | 7,15k | -5,35% |
| 2025-08-25 | Mr. Viju S. MenonGroup President of Global Quality & Operations | -500,00 | 195,31k | Verkauf | 390,61 | 12,71k | -3,79% |
| 2025-08-20 | Mr. Robert S. FletcherVP & Chief Legal Officer | -1,79k | 701,63k | Verkauf | 393,07 | 10,62k | -14,39% |
| 2025-08-06 | Ms. Ronda E. StrykerIndependent Director | -200,00k | 75,29M | Verkauf | 374,99 - 381,13 | 16,84M | -1,17% |
| 2025-08-01 | Kimberly Ann MontagninoInsider | -155,00 | 60,87k | Sale to Issuer | 392,73 | 1,21k | -11,37% |
| 2025-08-01 | Mr. Robert S. FletcherVP & Chief Legal Officer | -441,00 | 173,19k | Sale to Issuer | 392,73 | 12,40k | -3,43% |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
